Printer Friendly
The Free Library
18,914,768 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Riken Discovers New Mechanism for Controlling Allergic Reactions.


Tokyo, Japan, June 23, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Riken recently announced that the Research Center for Allergy and Immunology at Riken Yokohama Institute, in collaboration with Kyoto University Kyoto University (京都大学 Kyōto daigaku , has discovered a mechanism that controls allergic reactions allergic reaction
n.
A local or generalized reaction of an organism to internal or external contact with a specific allergen to which the organism has been previously sensitized.
.

The two partners have confirmed that a memory T-cell, a type of immune cell, controls the production of interleukin-4 (IL-4), an in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body.

in vi·vo
adj.
Within a living organism.



in vivo adv.
 protein that plays a role in allergic reactions.

Further, they have discovered that a memory T-cell transmits a signal called Notch, a kind of molecule, in the cells and increases the production of IL-4.

They expect that these findings will contribute to further research on allergy. Details of the research results will be published in the June issue of US scientific magazine Immunity.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jun 23, 2006
Words:130
Previous Article:Kobayashi Pharmaceutical, Aloe Pharmaceutical to Conclude Share Transfer Agreement.
Next Article:Kyowa Hakko Kogyo to Expand Its Fuji Plant and Accelerate R&D for Antibody Drugs.



Related Articles
Indoor air pollution: acute adverse health effects and host susceptibility.
Engineering allergy relief? (Molecular Biology).
Molecular mechanisms of allergic disease.(Featured CME Topic: Allergy)
Allergic and nonallergic drug reactions.(Featured CME Topic: Allergy)
Riken Vitamin to Bring to Market No-Oil/Cholesterol Mayonnaise in February.
RIKEN Elucidates Inactivation Mechanism of Gibberellin, Plant Growth-promoting Hormone.
RIKEN Elucidates Reaction Mechanism of Indoleamine 2,3-Dioxygenase.
RIKEN Research Center for Allergy and Immunology Discovers Mechanism for Regulating Immune Response.
New Gene Diagnosis Technology Can Diagnose the Efficacy Drugs Within 30 Minutes.
NEC, JST, and RIKEN Demonstrate World's First Controllably Coupled Qubits; New Circuit Technology Enables Execution of Quantum Algorithm.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles